This was written in November on their PR for NASH.
Post# of 148293
(Total Views: 438)
Posted On: 03/02/2020 9:27:31 AM
Re: Evil Rabbit #19905
This was written in November on their PR for NASH.
" CytoDyn plans to seek FDA approval for leronlimab in combination therapy and plans to complete the filing of a Biologics License Application (BLA) in 2019 for that indication."
You accuse me of lying, that's not correct.
" CytoDyn plans to seek FDA approval for leronlimab in combination therapy and plans to complete the filing of a Biologics License Application (BLA) in 2019 for that indication."
You accuse me of lying, that's not correct.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼